A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

The increasing knowledge on inflammatory pathways has driven the development of targeted biological therapies for severe refractory asthma. Among the recently developed biologics, the fully human monoclonal antibody dupilumab is an interesting therapeutic option, given its ability to inhibit the bio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Clin Risk Manag
Autors principals: Menzella, Francesco, Montanari, Gloria, Patricelli, Giulia, Cavazza, Alberto, Galeone, Carla, Ruggiero, Patrizia, Bagnasco, Diego, Facciolongo, Nicola
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636310/
https://ncbi.nlm.nih.gov/pubmed/31371974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S207402
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars